Teleflex Incorporated (NYSE:TFX – Get Free Report) announced a quarterly dividend on Thursday, November 5th. Shareholders of record on Monday, November 16th will be given a dividend of $0.34 per share by the medical technology company on Thursday, December 31st. This represents a $1.36 annualized dividend and a yield of 0.9%. The ex-dividend date is Monday, November 16th.
Teleflex has a payout ratio of 9.7% indicating that its dividend is sufficiently covered by earnings. Analysts expect Teleflex to earn $10.89 per share next year, which means the company should continue to be able to cover its $1.36 annual dividend with an expected future payout ratio of 12.5%.
Teleflex Stock Performance
Shares of NYSE:TFX traded up $1.98 on Thursday, hitting $151.85. 1,417,531 shares of the company were exchanged, compared to its average volume of 784,145. Teleflex has a 1-year low of $100.18 and a 1-year high of $156.67. The stock’s 50 day moving average price is $131.62 and its 200 day moving average price is $125.60. The company has a current ratio of 2.60, a quick ratio of 2.12 and a debt-to-equity ratio of 0.94. The firm has a market capitalization of $6.43 billion, a P/E ratio of -6.52, a price-to-earnings-growth ratio of 0.94 and a beta of 0.85.
Teleflex (NYSE:TFX – Get Free Report) last released its earnings results on Thursday, November 5th. The medical technology company reported $2.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.90 by $0.73. Teleflex had a positive return on equity of 11.93% and a negative net margin of 39.67%. The firm had revenue of $567.80 million for the quarter, compared to the consensus estimate of $565.52 million. During the same period in the prior year, the firm earned $3.67 EPS. The firm’s revenue was up .1% on a year-over-year basis. Sell-side analysts predict that Teleflex will post 7.22 EPS for the current year.
More Teleflex News
Here are the key news stories impacting Teleflex this week:
- Positive Sentiment: Adjusted EPS was $2.63, above consensus estimates of about $1.90–$1.92. Revenue of $567.8 million also topped the $565.5 million estimate. Teleflex Q3 Earnings Surpass Estimates
- Positive Sentiment: Revenue from continuing operations grew 0.2% year over year, or 3.0% on a pro forma adjusted constant-currency basis, suggesting underlying growth was stronger than the reported figure. Teleflex Reports Third Quarter Financial Results and Full Year 2026 Outlook
- Neutral Sentiment: Teleflex declared a quarterly dividend of $0.34 per share, equivalent to $1.36 annually and a 0.9% yield. Shareholders of record November 16 are scheduled to be paid December 31. Teleflex declares $0.34 dividend
- Negative Sentiment: Despite beating estimates, adjusted EPS declined from $3.67 a year earlier, and reported revenue growth was slight—factors that could temper enthusiasm about the quarter. Teleflex Q3 Earnings: Key Metrics Versus Estimates
Teleflex Company Profile
Teleflex Incorporated is a global medical technology company that develops, manufactures and markets specialty medical devices. Its products are designed to support healthcare professionals in critical care and procedural settings, including vascular access, interventional cardiology and radiology, anesthesia, respiratory care, emergency medicine, surgical applications and urology.
The company’s portfolio includes catheters, access and closure devices, airway-management products, surgical instruments, pain-management devices and other technologies used in hospitals and outpatient facilities.
Recommended Stories
- Five stocks we like better than Teleflex
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.
